Your Health, We Care
The New England Journal of Medicine has published the latest research article on the treatment of advanced renal cell carcinoma with lenvatinib combined with pembrolizumab or everolimus.
Eisai and other pharmaceutical companies are continuing to investigate the potential applications of lenvatinib in other types of tumors, including non-small cell lung cancer, cancer, and others.
